Inderbir Singh Gill, MD

Inderbir S. Gill, MD, is Chairman & Distinguished Professor, Catherine & Joseph Aresty Department of Urology; Executive Director, USC Institute of Urology; and the Shirley & Donald Skinner Chair in Urologic Cancer Surgery at the Keck School of Medicine, University of Southern California, Los Angeles. Prior to this, he was chairman & professor, department of urology at the Cleveland Clinic, Cleveland, OH, where he was on faculty for 12 years (1997-2009).

During his 15 years in Los Angeles since 2009, USC Urology has grown in scientific stature, clinical volumes, financial productivity & philanthropy. As a result, USC Urology has progressed in U.S. News & World Report national rankings from being outside the ‘Top 50’ until 2011, to #4 in 2019, and has ranked in the ‘Top 10’ for 5 years in a row (2018-2022). In NIH Blue Ridge national rankings, USC Urology elevated from #26 in 2017 to #2 nationally (2022, 2023).

Dr Gill has published ~1,017 scientific papers with ~53,807 citations. His H-index is 123, amongst the highest in the entire field of urology https://www.scopus.com/authid/detail.uri?authorId=35415354700. He is principal investigator of a funded R-01 grant from NCI, and co-PI on other NIH grants. He is published in prestigious journals including N. Engl. J. Med., Nature, Nature Medicine, Lancet, Lancet Oncology, JAMA Surgery, etc. He has edited/co-edited 10 textbooks and has been on the editorial boards of 9 urologic journals. Dr Gill has been invited for over 450 visiting professorships, invited lectures and live surgery demonstrations world-wide. He is elected to the prestigious American Association of Genito-Urinary Surgeons (2003) and the Clinical Society of AAGUS (2009).

His various honors include: the Dr. B. C. Roy National Award for Eminent Medical Person awarded by the President of India (2005); St. Paul’s Medal by the British Urological Association (2006); honorary Fellow of the Royal College of Surgeons of England; President, 24th World Congress of Endourology & SWL (2006); USC Presidential Medallion (2013); listed in Thomson Reuters “The World’s Most Influential Scientific Minds” (2014); AUA Ramon Guiteras Lecturer (2015); AUA Chair, Global Initiatives (2015-2017); AAGUS Membership Committee (2021-2025); AUA Presidential Citation for Outstanding Contributions to Robotic Urologic Oncologic Surgery (2022); and SIU Distinguished Career Award by the Societe’ Internationale D’ Urologie (2022); and the Spence Medal from the AAGUS (2024), one of the highest honors in the field.

To date, Dr Gill has had the privilege to train over 120 urology residents and over 140 post-graduate fellows in robotic & minimally invasive urologic oncologic surgery. His fellows and faculty members are also making innovative contributions to the field, and notably, at this writing, 14 of them are current Chairs of prestigious urology departments in the U.S. and internationally.

His primary academic focus is advanced robotic urologic oncologic surgery for cancers of the kidney, bladder and prostate. His aggregate team has amongst the world’s pre-eminent robotic/laparoscopic case volumes for urologic oncologic surgery, with over 15,000+ cases in the USA. More recently, his interest has expanded to focal targeted therapy for prostate cancer. He and his team are now exploring artificial intelligence (AI) applications in urology. In 2021, under his leadership, USC Urology established the first, foundation-funded, dedicated Urology AI Center in a urology department in the nation.

On May 4, 2025, Dr Gill and Dr Nassiri performed the world’s first-in-human bladder transplant. https://www.nytimes.com/2025/05/18/health/bladder-transplant-human.html.

• Time Magazine: “100 Most Influential People in Healthcare”, 2026
• American Association of Urologic Surgeons: Chair, Membership Committee, 2025
• LA Business Journal: Outstanding Collaboration of the Year, 2025
• LA Business Journal: Best Innovation in Healthcare Award, 2024
• American Association of Urologic Surgeons: Spence Medal, 2024
• AUA Presidential Citation for Outstanding Contributions to Robotic Urologic Oncologic Surgery, 2022
• Societe’ Internationale d’Urology (SIU) Distinguished Career Award, 2022
• University of Southern California, Los Angeles, CA: Distinguished Professor of Urology, 2017
• American Urological Association: Global Initiatives Chair, 2015
   – 2018
• American Urology Association Annual: Ramon Guiteras Lecturer, 2015
• Thomson Reuters: Ranked among “The World’s Most Influential Scientific Minds.”, 2014
• University of Southern California: USC Presidential Medallion, 2013
• Top Doctors: Pasadena Magazine, 2011
• Urologic Society for Renal Transplantation and Renal Srugery: President, 2009
• 24th World Congress of Endourology: President, 2006
• British Urological Association: St. Paul’s Medal, 2006
• Royal College of Surgeons of Edinburgh: Honorary Fellow, 2005
• President of India for Eminent Medical Person in India: Dr. B.C. Roy National Award, 2005
• Honorary Fellow of the Royal College of Surgeons of Edinburgh, 2005
• Elected to the American Association of Genitourinary Surgeons, 2003
• Cleveland Magazine: Listed in Best Doctors in Cleveland area, 1998
   – 2005
• 1998
   -: Listed in Best Doctors in America, 1998
   – 2002
• University of Nebraska Medical Center: Pfizer Scholars in Urology Award, 1996

• Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy
  NIH · R01CA205058 · Sep 2, 2016 – Aug 31, 2021 · Role: Principal Investigator
• Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness
  NIH · R21CA201865 · Jul 1, 2016 – Jun 30, 2019 · Role: Co-Principal Investigator

• Surgeons Perform First Human Bladder Transplant
• USC urologists take robot to next level in thrombectomy
• Renowned Surgeon Inderbir Gill Welcomed
• Keck Medical Center of USC surgeon becomes first in world to use FDA cleared advanced robotic technology to remove kidney tumor in outpatient procedure
• Keck News: Inderbir Gill Named Chair of Department of Urology
• NEW PROSTATE CANCER TREATMENT OFFERS NON-SURGICAL ALTERNATIVE
• Keck News: Innovation Draws Patients Worldwide

• GUSL: A novel and efficient machine learning model for prostate segmentation on MRI. Comput Biol Med. 2026 Aug 15; 213:111820.. View in PubMed
• Improving readability of layperson abstracts and summaries in oncology using task-specific large language model powered tool: results from the BRIDGE-AI 7 study. JAMIA Open. 2026 Jun; 9(3):ooag082.. View in PubMed
• Combined bladder-kidney transplantation: first-in-human feasibility trial. Lancet. 2026 Jul 04; 408(10549):31-37.. View in PubMed
• Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy. BJU Int. 2026 Jun 15.. View in PubMed
• Association between surgeon experience, level of supervision, and outcomes after hip fracture. Bone Jt Open. 2026 Jun 04; 7(6):744-752.. View in PubMed
• Comparative Effectiveness and Cost-Effectiveness of an Artificial Intelligence Workflow for Small Renal Mass Diagnosis on Computed Tomography. Urol Pract. 2026 Jun 03; 101097.. View in PubMed
• Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes. Urol Oncol. 2026 Jul; 44(7):391-399.. View in PubMed
• Management of Femoral Head Fractures: A Systematic Review. Cureus. 2026 May; 18(5):e109127.. View in PubMed
• Pain Perception During Transperineal and Transrectal Prostate Biopsy Under Local An-esthesia: a Prospective Analysis of a Multi-ethnic and Diverse Cohort. Int Braz J Urol. 2026 May-Jun; 52(3).. View in PubMed
• Post pelvic binder radiograph can identify bladder injury associated with pelvic trauma: A multi-centre observational study. Injury. 2026 Jun; 57(6):113272.. View in PubMed
• A transparent, lightweight and sustainable Green Learning AI model for prostate cancer detection on MRI. BJU Int. 2026 Jun; 137(6):1014-1025.. View in PubMed
• Machine learning based classification of aggressive and malignant renal tumors from multimodal data. PLOS Digit Health. 2026 Feb; 5(2):e0001225.. View in PubMed
• Leveraging generative AI to enhance doctor-patient communication. Nat Rev Urol. 2026 Feb 05.. View in PubMed
• Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsies. Biomark Res. 2026 Jan 16; 14(1):18.. View in PubMed
• Can Urinary Diversion Type Affect Postoperative Complications Following Radical Cystectomy in Female Patients? Int J Urol. 2026 Jan; 33(1):e70330. Zahir M, Moghadam FS, Ladi-Seyedian SS, Ghoreifi A, M . View in PubMed
• Readability Optimization of Layperson Summaries in Urological Oncology Clinical Trials: Outcomes from the BRIDGE-AI 8 Study. Curr Oncol. 2025 Dec 10; 32(12).. View in PubMed
• Clinical outcomes following treatment of extracapsular hip fractures with long compared with short cephalomedullary nails. Bone Joint J. 2025 Dec 01; 107.. View in PubMed
• Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial. JCO Clin Cancer Inform. 2025 Sep; 9:e2500042.. View in PubMed
• Risk factors associated with the development of complications after a hip fracture. Bone Joint J. 2025 09 01; 107.. View in PubMed
• Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration. Eur Urol Focus. 2025 Nov; 11(6):921-925.. View in PubMed
• Image Imputation with conditional generative adversarial networks captures clinically relevant imaging features on computed tomography. PLOS Digit Health. 2025 Aug; 4(8):e0000970.. View in PubMed
• Impact of magnetic resonance imaging visibility of prostate cancer on partial gland ablation. BJUI Compass. 2025 Aug; 6(8):e70065.. View in PubMed
• The Current State of Artificial Intelligence for Benign Prostatic Hyperplasia. Eur Urol Focus. 2025 Nov; 11(6):999-1003.. View in PubMed
• Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0. Radiology 2025;315:e24014. Eur Urol. 2025 Nov; 88(5):e101-e102.. View in PubMed
• Radiogenomic correlation of hypoxia-related biomarkers in clear cell renal cell carcinoma. J Cancer Res Clin Oncol. 2025 Jun 12; 151(6):186.. View in PubMed
• Prediction of PD-L1 and CD68 in Clear Cell Renal Cell Carcinoma with Green Learning. J Imaging. 2025 Jun 10; 11(6).. View in PubMed
• The outcomes of salvage robotic radical prostatectomy following radiation versus focal therapy: Does the primary treatment modality matter? BJUI Compass. 2025 May; 6(5):e70019. Ghoreifi A, Ramacciotti . View in PubMed
• Awareness and use of generative AI-powered tools: results of one-year follow-up prospective cross-sectional global survey. Minerva Urol Nephrol. 2025 Aug; 77(4):528-537.. View in PubMed
• Large language models for automating clinical trial matching. Curr Opin Urol. 2025 05 01; 35(3):250-258.. View in PubMed
• Contemporary outcomes for robotic radical cystectomy and intracorporeal neobladder urinary diversion. Urol Oncol. 2025 06; 43(6):392.e13-392.e21.. View in PubMed
• The risk of complications after hip fracture. Bone Joint J. 2025 03 01; 107.. View in PubMed
• Brief Cognitive Analytic Therapy (CAT)-Informed Reformulation for Young People With Eating Disorders: A Case Series. Clin Psychol Psychother. 2025 Mar-Apr; 32(2):e70043.. View in PubMed
• Generative artificial intelligence in oncology. Curr Opin Urol. 2025 05 01; 35(3):205-213.. View in PubMed
• Outcomes of Minimally Invasive Nephrectomy Following Immune-Checkpoint Inhibitor Therapy: A Multicenter Propensity Score-Matched Analysis. J Endourol. 2025 Apr; 39(4):399-404.. View in PubMed
• Letter: Generative Artificial Intelligence Platform for Automating Social Media Posts From Urology Journal Articles: A Cross-Sectional Study and Randomized Assessment. J Urol. 2025 Mar; 213(3):380-381.. View in PubMed
• The Safety and Feasibility of Aquablation in Patients with Previous Surgery for Benign Prostatic Hyperplasia. J Endourol. 2025 Jan; 39(1):50-55.. View in PubMed
• Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study. Eur Urol Focus. 2025 Mar; 11(2):266-272.. View in PubMed
• A sustainable and expedited ‘One-Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility. BJUI Compass. 2024 Dec; 5(12):1278-1287.. View in PubMed
• Transperineal versus Transrectal MRI/TRUS fusion-guided prostate biopsy in a large, ethnically diverse, and multiracial cohort. Int Braz J Urol. 2024 Sep-Oct; 50(5):616-628.. View in PubMed
• Single-Port Robot assisted partial cystectomy for urachal adenocarcinoma. Int Braz J Urol. 2024 Sep-Oct; 50(5):659-660.. View in PubMed
• The learning curve for transperineal MRI/TRUS fusion prostate biopsy: A prospective evaluation of a stepwise approach. Urol Oncol. 2025 01; 43(1):64.e1-64.e10.. View in PubMed
• Generative Artificial Intelligence Platform for Automating Social Media Posts From Urology Journal Articles: A Cross-Sectional Study and Randomized Assessment. J Urol. 2024 12; 212(6):873-881.. View in PubMed
• Perioperative and extended outcomes of patients undergoing parastomal hernia repair following cystectomy and ileal conduit. World J Urol. 2024 Aug 12; 42(1):482.. View in PubMed
• Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus. BJS Open. 2024 Jul 02; 8(4).. View in PubMed
• PCa-RadHop: A transparent and lightweight feed-forward method for clinically significant prostate cancer segmentation. Comput Med Imaging Graph. 2024 09; 116:102408.. View in PubMed
• Accuracy, readability, and understandability of large language models for prostate cancer information to the public. Prostate Cancer Prostatic Dis. 2025 Jun; 28(2):394-399.. View in PubMed
• A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRI Int Braz J Urol. 2024 May-Jun; 50(3):319-334. Kaneko M , Fujihara A, Iwata T, Ramacciotti LS, Pal . View in PubMed
• Study protocol for the Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) global cross-specialty surveys and consensus. PLoS One. 2024; 19(4):e0297799.. View in PubMed
• Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized Clinical Trial. J Urol. 2024 06; 211(6):743-753.. View in PubMed
• Neuronally differentiated macula densa cells regulate tissue remodeling and regeneration in the kidney. J Clin Invest. 2024 Apr 10; 134(11).. View in PubMed
• Reply by Authors. J Urol. 2024 Jun; 211(6):751.. View in PubMed
• Reply by Authors. J Urol. 2024 Jun; 211(6):752-753.. View in PubMed
• Generative artificial intelligence in surgery. Surgery. 2024 06; 175(6):1496-1502.. View in PubMed
• The effect of enhanced recovery after surgery on oncologic outcome following radical cystectomy for urothelial bladder carcinoma. Surg Oncol. 2024 Jun; 54:102061.. View in PubMed
• Blood-based liquid biopsy: A promising noninvasive test in diagnosis, surveillance, and prognosis of patients with upper tract urothelial carcinoma. Urol Oncol. 2024 04; 42(4):118.e9-118.e17.. View in PubMed
• Robotic Radical Cystectomy for Bladder Cancer: The Way Forward. J Urol. 2024 03; 211(3):476-480.. View in PubMed
• Publishers’ and journals’ instructions to authors on use of generative artificial intelligence in academic and scientific publishing: bibliometric analysis. BMJ. 2024 01 31; 384:e077192.. View in PubMed
• Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng’s Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.. View in PubMed
• Conditional generative learning for medical image imputation. Sci Rep. 2024 01 02; 14(1):171.. View in PubMed
• Diversity in Renal Mass Data Cohorts: Implications for Urology AI Researchers. Oncology. 2024; 102(7):574-584.. View in PubMed
• The Impact of Telemedicine in Reducing the Carbon Footprint in Health Care: A Systematic Review and Cumulative Analysis of 68 Million Clinical Consultations. Eur Urol Focus. 2023 11; 9(6):873-887.. View in PubMed
• SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer. Cancer Res. 2023 11 15; 83(22):3813-3826.. View in PubMed
• Criteria for enhancing reporting of perioperative transfusions in surgical and anaesthesiological studies. Br J Surg. 2023 11 09; 110(12):1655-1658.. View in PubMed
• Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024 02; 85(2):146-153.. View in PubMed
• Impact of persistent PSA after salvage radical prostatectomy: a multicenter study. Prostate Cancer Prostatic Dis. 2024 Dec; 27(4):686-692.. View in PubMed
• Generative Artificial Intelligence in Health Care. J Urol. 2023 11; 210(5):723-725.. View in PubMed
• Reply to Laura E. Davis, Adam Calaway, and Laura Bukavina’s Letter to the Editor re: Nima Nassiri, Giovanni Cacciamani, Inderbir S. Gill. Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor. Eur Urol. 2023;84:517-518.. View in PubMed
• Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium. Eur Urol Focus. 2024 May; 10(3):461-468.. View in PubMed
• Radiomics Correlation to CD68+ Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma. Oncology. 2024; 102(3):260-270.. View in PubMed
• Comprehensive Assessment of MRI-based Artificial Intelligence Frameworks Performance in the Detection, Segmentation, and Classification of Prostate Lesions Using Open-Source Databases. Urol Clin North Am. 2024 Feb; 51(1):131-161.. View in PubMed
• Robotic Bladder Autotransplantation: Preclinical Studies in Preparation for First-in-human Bladder Transplant. J Urol. 2023 10; 210(4):600-610.. View in PubMed
• Reply by Authors. Urol Pract. 2023 09; 10(5):445.. View in PubMed
• The Novel Green Learning Artificial Intelligence for Prostate Cancer Imaging: A Balanced Alternative to Deep Learning and Radiomics. Urol Clin North Am. 2024 Feb; 51(1):1-13.. View in PubMed
• Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison. Sci Rep. 2023 08 18; 13(1):13457.. View in PubMed
• Artificial intelligence and urology: ethical considerations for urologists and patients. Nat Rev Urol. 2024 01; 21(1):50-59.. View in PubMed
• Robot Partial Prostatectomy for Anterior Cancer: Long-term Functional and Oncological Outcomes at 7 Years. Eur Urol Open Sci. 2023 Sep; 55:11-14.. View in PubMed
• Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function. Eur Urol Focus. 2024 Jan; 10(1):169-181.. View in PubMed
• Evaluating the Effectiveness of Artificial Intelligence-powered Large Language Models Application in Disseminating Appropriate and Readable Health Information in Urology. J Urol. 2023 10; 210(4):688-694.. View in PubMed
• Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. Eur Urol. 2023 12; 84(6):547-560.. View in PubMed
• Bridging the Gap Between Urological Research and Patient Understanding: The Role of Large Language Models in Automated Generation of Layperson’s Summaries. Urol Pract. 2023 09; 10(5):436-443.. View in PubMed
• EphrinB2: Expression of a novel potential target in renal cell carcinoma. Indian J Urol. 2023 Jul-Sep; 39(3):223-227.. View in PubMed
• Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor. Eur Urol. 2023 11; 84(5):517-518.. View in PubMed
• Need to define hostile surgical sites to enhance surgical planning and outcomes. Br J Surg. 2023 06 12; 110(7):739-742.. View in PubMed
• Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy. Cancers (Basel). 2023 Jun 09; 15(12).. View in PubMed
• ChatGPT: standard reporting guidelines for responsible use. Nature. 2023 Jun; 618(7964):238.. View in PubMed
• Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center. Int Braz J Urol. 2023 May-Jun; 49(3):351-358.. View in PubMed
• Bibliometric analysis of academic journal recommendations and requirements for surgical and anesthesiologic adverse events reporting. Int J Surg. 2023 May 01; 109(5):1489-1496.. View in PubMed
• Severity Grading Systems for Intraoperative Adverse Events. A Systematic Review of the Literature and Citation Analysis. Ann Surg. 2023 11 01; 278(5):e973-e980.. View in PubMed
• Impact of smoking on urologic cancers: a snapshot of current evidence. World J Urol. 2023 Jun; 41(6):1473-1479.. View in PubMed
• Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study. Oncology. 2023; 101(6):375-388.. View in PubMed
• Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. 2023 12; 6(6):604-610.. View in PubMed
• Association between early postradical cystectomy kidney injury and perioperative outcome in enhanced recovery era. Urol Oncol. 2023 09; 41(9):389.e15-389.e20.. View in PubMed
• Transperineal magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsy under local anaesthesia: the ‘double-freehand’ technique. BJU Int. 2023 06; 131(6):770-774.. View in PubMed
• Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. World J Urol. 2023 Mar; 41(3):747-755.. View in PubMed
• Reply by Authors. J Urol. 2023 05; 209(5):862.. View in PubMed
• Patient-reported Satisfaction and Regret Following Focal Therapy for Prostate Cancer: A Prospective Multicenter Evaluation. Eur Urol Open Sci. 2023 Apr; 50:10-16.. View in PubMed
• A Urine-based DNA Methylation Marker Test to Detect Upper Tract Urothelial Carcinoma: A Prospective Cohort Study. J Urol. 2023 05; 209(5):854-862.. View in PubMed
• Recommendations for Intraoperative Adverse Events Data Collection in Clinical Studies and Study Protocols. An ICARUS Global Surgical Collaboration Study. Int J Surg Protoc. 2023; 27(1):23-83.. View in PubMed
• Assessment and Reporting of Perioperative Adverse Events and Complications in Patients Undergoing Inguinal Lymphadenectomy for Melanoma, Vulvar Cancer, and Penile Cancer: A Systematic Review and Meta-analysis. World J Surg. 2023 04; 47(4):962-974.. View in PubMed
• Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort. Eur Urol Focus. 2023 07; 9(4):645-649.. View in PubMed

• Daneshmand, Siamak
• Desai, Mihir
• Djaladat, Hooman